Not applicableUnknownNCT05649163
What this trial is testing
Real-world Study of HER2-overexpressed Advanced Solid Tumors After Progression of First-line Standard Therapy
Who this might be right for
HER2Advanced Gastric CancerAdvanced Gastroesophageal Junction Adenocarcinoma+1 more
Shen Lin 306